Phillips Eye Institute

Details Doctors
Medical Suppliers In Minnesota

Name :

Phillips Eye Institute

Address  :

2215 Park Avenue

Town  :

Minneapolis

State  :

Minnesota

Country  :

USA

Post Code:

55404

Phone  :

612 775 8800

Web URL  :

Available
Specialization
  • Ophthalmology
Facilities

History
Our History
Phillips Eye Institute was the vision of many people designed to function as a free standing eye specialty center associated with Mount Sinai Medical Center It was developed by and for ophthalmologists The dream of creating this unique facility was realized because of the persistence determination and resourcefulness of a large group of people

Jay Phillips was the main benefactor of Mount Sinai Hospital and a strong supporter of Mount Sinais Division of Ophthalmology Because of his generous philanthropic support Phillips Eye Institute bears his name

1987
Phillips Eye Institute construction complete

1988
Mount Sinai Hospital merges with Metropolitan Medical Center to become Metropolitan Mount Sinai Medical Center MMS

1990
PEIs Inpatient Unit opens

1991
PEI continues its legacy surviving the closure of MMS

1993
Health One and LifeSpan merge to form the HealthSpan Health Systems Corporation

1993
PEI is congressionally designated as an eye specialty hospital

1994
HealthSpan and Medica merge to become Allina Health System PEI is the only specialty hospital in the Allina Health System

1997
Phillips Eye Institute celebrates its 10th anniversary recognizing a rich history of commitment to eye health care

2008
Phillips Eye Institute opens a second location at Buffalo Hospital
NEWS
Menthol cigarettes may increase stroke risk study says

WASHINGTON DC WUSA Menthol cigarette smokers are more likely to have a history of stroke than smokers who prefer other types of cigarettes according to a new study published in the April 9 issue of Archives of Internal Medicine Researchers found that menthol cigarette smokers were more than twice as likely to have a stroke than nonmenthol smoke... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More